Aliva Biopharmaceuticals' Grant

Aliva Biopharmaceuticals raised a round of funding on January 14, 2008. Investors include National Science Foundation.

Aliva Biopharmaceuticals is a company that received a SBIR Phase I grant for a project entitled: Humanized Mouse Ig system employing BAC. Their research project aims to introduce the entire human immu…

Articles about Aliva Biopharmaceuticals' Grant: